Back
Caribou Biosciences Vs. Lexicon Pharmaceuticals Industry Stock Comparison
Sell
20
CRBU
Caribou Biosciences
Last Price:
1.87
Seasonality Move:
-17.65%
Sell
27
LXRX
Lexicon Pharmaceuticals
Last Price:
1.69
Seasonality Move:
3.83%
Sell
20
Caribou Biosciences (CRBU)
is a Sell
Is Caribou Biosciences a Buy, Sell or Hold?
- The current Caribou Biosciences [CRBU] share price is $1.87. The Score for CRBU is 20, which is 60% below its historic median score of 50, and infers higher risk than normal.
- CRBU is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk could be especially high.
Sell
27
Lexicon Pharmaceuticals (LXRX)
is a Sell
Is Lexicon Pharmaceuticals a Buy, Sell or Hold?
- The current Lexicon Pharmaceuticals [LXRX] share price is $1.69. The Score for LXRX is 27, which is 46% below its historic median score of 50, and infers higher risk than normal.
- LXRX is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
CRBU Stock Price Chart
What is Caribou Biosciences's stock price today?
-
The Caribou Biosciences share price today is $1.87
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CRBU is experiencing slight buying pressure.
LXRX Stock Price Chart
What is Lexicon Pharmaceuticals's stock price today?
-
The Lexicon Pharmaceuticals share price today is $1.69
The current trend is relatively stagnant and LXRX is experiencing buying pressure, which is a positive indicator for future bullish movement.
CRBU Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.05 | Sell |
| Relative Strength Index (14 RSI): | 44.67 | Sell |
| Chaikin Money Flow: | 108658 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (1.83 - 2.07) | Sell |
| Bollinger Bands (100): | (1.68 - 2.62) | Sell |
LXRX Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.03 | Sell |
| Relative Strength Index (14 RSI): | 54.09 | Buy |
| Chaikin Money Flow: | 1640628 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (1.58 - 1.68) | Buy |
| Bollinger Bands (100): | (1.57 - 1.97) | Sell |
CRBU Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 1.88 | Sell |
| 20-day SMA: | 1.96 | Sell |
| 50-day SMA: | 2.03 | Sell |
| 200-day SMA: | 3.82 | Sell |
| 8-day EMA: | 1.87 | Sell |
| 20-day EMA: | 1.93 | Sell |
| 50-day EMA: | 2.05 | Sell |
| 200-day EMA: | 3.32 | Sell |
LXRX Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 1.59 | Buy |
| 20-day SMA: | 1.62 | Buy |
| 50-day SMA: | 1.72 | Sell |
| 200-day SMA: | 1.88 | Sell |
| 8-day EMA: | 1.62 | Buy |
| 20-day EMA: | 1.63 | Buy |
| 50-day EMA: | 1.69 | Sell |
| 200-day EMA: | 1.81 | Sell |
Caribou Biosciences Earnings Growth & CRBU Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.08 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.53 per share, and a decrease next year of $0.12 per share.
Lexicon Pharmaceuticals Earnings Growth & LXRX Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.01 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.11 per share, and an increase next year of $0.13 per share.
Caribou Biosciences Technical Analysis
| Sep 23 | Sep 24 | Sep 25 | Sep 26 | Sep 27 | Sep 30 | Oct 1 | Oct 2 | Oct 3 | Oct 4 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep | Oct | |||||||||
| 23 | 24 | 25 | 26 | 27 | 30 | 01 | 02 | 03 | 04 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Lexicon Pharmaceuticals Technical Analysis
| Sep 23 | Sep 24 | Sep 25 | Sep 26 | Sep 27 | Sep 30 | Oct 1 | Oct 2 | Oct 3 | Oct 4 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep | Oct | |||||||||
| 23 | 24 | 25 | 26 | 27 | 30 | 01 | 02 | 03 | 04 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||